registHER: patient characteristics and time course of CNS metastases in patients with HER2-positive metastatic breast cancer.

被引：0
|
作者：
Yardley, D. A.
Kaufman, P. A.
Mayer, M.
Ulcickas, Yood M.
Tan-Chiu, E.
Brufsky, A. M.
Rugo, H. S.
Tripathy, D.
Brammer, M. G.
Paik, S.
机构：
[1] Sarah Cannon Res Inst, Nashville, TN USA
[2] Dartmouth Hitchcock Med Ctr, Lebanon, NH 03766 USA
[3] Patient Advocate, New York, NY USA
[4] Yale Univ, Sch Med, EpiSource LLC, New Haven, CT USA
[5] Florida Canc Care, Tamarac, FL USA
[6] Univ Pittsburgh, Ctr Canc, Pittsburgh, PA USA
[7] Univ Calif San Francisco, Ctr Comprehens Canc, San Francisco, CA 94143 USA
[8] Univ Texas SW Med Ctr, Dallas, TX USA
[9] Genentech Inc, San Francisco, CA USA
[10] Natl Surg Breast & Bowel Project, Pittsburgh, PA USA
来源：
BREAST CANCER RESEARCH AND TREATMENT | 2007年 / 106卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S263 / S264
页数：2
相关论文
共 50 条
  • [41] HER2-positive metastatic breast cancer: A changing scenario
    Mustacchi, G.
    Biganzoli, L.
    Pronzato, P.
    Montemurro, F.
    Dambrosio, M.
    Minelli, M.
    Molteni, L.
    Scaltriti, L.
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2015, 95 (01) : 78 - 87
  • [42] Trastuzumab emtansine in HER2-positive metastatic breast cancer
    Montemurro, Filippo
    LANCET ONCOLOGY, 2017, 18 (06): : 696 - 697
  • [43] Overcoming resistance in Her2-positive metastatic breast cancer
    Oksuzoglu, Omur Berna
    LEUKEMIA RESEARCH, 2018, 73 : S13 - S13
  • [44] HER2-Positive Metastatic Breast Cancer: A Comprehensive Review
    Exman, Pedro
    Tolaney, Sara M.
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2021, 19 (01) : 40 - 50
  • [45] Optimizing treatment of HER2-positive metastatic breast cancer
    Jones, AL
    Leyland-Jones, B
    SEMINARS IN ONCOLOGY, 2004, 31 (05) : 29 - 34
  • [46] Advancing outcomes of metastatic HER2-positive breast cancer
    Chumsri, Saranya
    LANCET, 2023, 401 (10390): : 1746 - 1747
  • [47] Margetuximab for the treatment of HER2-positive metastatic breast cancer
    Tarantino, Paolo
    Morganti, Stefania
    Uliano, Jacopo
    Giugliano, Federica
    Crimini, Edoardo
    Curigliano, Giuseppe
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2021, 21 (02) : 127 - 133
  • [48] Therapy of cerebral metastatic, HER2-positive Breast Cancer
    Lorenz, Judith
    GEBURTSHILFE UND FRAUENHEILKUNDE, 2019, 79 (11)
  • [49] Pertuzumab biosimilar in HER2-positive metastatic breast cancer
    Lorenz, Judith
    GEBURTSHILFE UND FRAUENHEILKUNDE, 2025, 85 (01) : 21 - 21
  • [50] Optimizing the Management of Metastatic HER2-Positive Breast Cancer
    Goel S.
    Tolaney S.
    Current Breast Cancer Reports, 2015, 7 (4) : 190 - 202
12345